Financials in USD. Standardized financial statements.
A compact view of how Emmaus Life Sciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $12.45M | $16.65M | $29.60M | $18.39M | $20.61M | $23.17M | $22.75M | $1.32M | $128,500 | $85,100 |
| Revenue Growth? | -25.2% | -43.7% | +60.9% | -10.8% | -11.0% | +1.8% | +1628.9% | +924.1% | +51.0% | 0.0% |
| Cost of Revenue? | $857,000 | $1.20M | $1.34M | $2.59M | $3.31M | $2.25M | $1.09M | $827,400 | $53,500 | $5,500 |
| Gross Profit? | $11.60M | $15.45M | $28.25M | $15.80M | $17.30M | $20.92M | $21.66M | $488,100 | $75,000 | $79,600 |
| Gross Margin? | +93.1% | +92.8% | +95.5% | +85.9% | +83.9% | +90.3% | +95.2% | +37.1% | +58.4% | +93.5% |
| Operating Expenses? | $11.37M | $17.35M | $24.71M | $22.39M | $23.43M | $20.95M | $26.17M | $10.29M | $7.18M | $3.85M |
| Operating Income? | $231,000 | -$1.89M | $3.54M | -$6.59M | -$6.13M | -$32,000 | -$4.51M | -$10.24M | -$7.10M | -$3.77M |
| EBITDA? | -$310,000 | -$910,000 | $3.62M | -$5.50M | -$12.76M | $7.02M | -$26.98M | -$10.13M | -$7.05M | -$3.76M |
| Income Before Tax | -$7.48M | -$6.42M | -$3.79M | -$10.56M | -$15.92M | $973,000 | -$54.68M | -$10.33M | -$7.11M | -$5.94M |
| Income Tax Expense | $9,000 | $29,000 | -$59,000 | $60,000 | $25,000 | -$381,000 | $164,000 | $1,900 | $2,600 | $2,000 |
| Net Income? | -$7.49M | -$6.45M | -$3.73M | -$10.63M | -$15.95M | $1.35M | -$54.84M | -$9.60M | -$7.11M | -$5.94M |
| EPS? | $-0.12 | $-0.10 | $-0.07 | $-0.21 | $-0.32 | $0.03 | $-1.30 | $-11.16 | $-15.15 | $-55.54 |
| Diluted EPS? | $-0.12 | $-0.10 | $-0.07 | $-0.21 | $-0.32 | $0.03 | $-1.30 | $-11.16 | $-15.15 | $-55.54 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality